Nanobiotix S.A.
NBTX
$28.23
-$2.08-6.86%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.85% | 88.51% | 3.04% | -116.03% | 0.85% |
| Total Depreciation and Amortization | 7.84% | -5.43% | -3.04% | 8.25% | -0.84% |
| Total Amortization of Deferred Charges | 0.00% | 0.00% | 0.00% | -- | -- |
| Total Other Non-Cash Items | -7.85% | -148.21% | -3.04% | 909.66% | -0.85% |
| Change in Net Operating Assets | 7.84% | -19.22% | -3.04% | -83.03% | -0.85% |
| Cash from Operations | -7.85% | -25.33% | 3.04% | -140.04% | 0.85% |
| Capital Expenditure | -7.86% | 58.54% | 3.01% | 25.46% | 0.83% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.94% | 87.93% | 3.15% | -813.56% | 1.67% |
| Cash from Investing | -7.86% | 64.87% | 3.04% | 7.06% | 0.85% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -18.26% | 0.00% | -3.08% | 0.00% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | 9.43% | 0.00% | 39.08% | 0.00% |
| Cash from Financing | -7.84% | -12.66% | 3.04% | 4.59% | 0.85% |
| Foreign Exchange rate Adjustments | -7.82% | -1,096.32% | -2.86% | 21.21% | -0.86% |
| Miscellaneous Cash Flow Adjustments | -20.00% | -200.00% | -16.67% | -- | -- |
| Net Change in Cash | -7.85% | -24.42% | 3.04% | -89.47% | 0.85% |